JMJoana Marques

Joana Marques

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Joana Marques has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long-term blood-free rearing of Anopheles mosquitoes with no effect on fitness, Plasmodium infectivity nor microbiota composition

    by Joana Marques, Sofia G. Seabra, Inês Almeida, Joana Gomes, Ana Catarina Alves, Henrique Silveira

    Mosquito-borne diseases kill millions of people each year. Therefore, many innovative research and population control strategies are being implemented but, most of them require large-scale production of mosquitoes. Mosquito rearing depends on fresh blood from human donors, experimentation animals or slaughterhouses, which constitutes a strong drawback since high blood quantities are needed, raising ethical and financial constraints. To eliminate blood dependency and the use of experimentation animals, we previously developed BLOODless, a patented diet that represents an important advance towards sustainable mosquito breeding in captivity. BLOODless diet was used to maintain a colony of Anopheles stephensi for 40 generations. Bloodmeal appetite, fitness, Plasmodium berghei infectivity, whole genome sequencing and microbiota were evaluated over time. Here we show that BLOODless can be implemented in Anopheles insectaries since it allows long-term rearing of mosquitoes in captivity, without a detectable effect on their fitness, infectivity, nor on their midgut and salivary microbiota composition.


  • Open Access

    A Blood-Free Diet to Rear Anopheline Mosquitoes

    by Joana Marques, João C. R. Cardoso, Rute C. Félix, Deborah M. Power, Henrique Silveira

    Malaria research requires large-scale breeding and production conditions for mosquitoes (Anopheles spp.) in captivity. The sustainable and reliable production of mosquitoes is currently inhibited by the supply of fresh vertebrate blood. Alternatives to blood are required to promote efficient control strategies for malaria and other vector borne diseases that are transmitted by blood feeding insects. With this in mind, artificial liquid diets were formulated as substitutes for fresh vertebrate blood. Herein we report a blood-free artificial liquid diet that delivers feeding rates similar to blood and mimics the physiological effects of a fresh vertebrate blood meal. The diet induces ovarian and egg maturation of Anopheles mosquitoes and also produces good larval survival and development of functional adults. The formulated blood-free liquid diet is an important advance towards sustainable mosquito breeding in captivity and will reduce the maintenance costs of mosquito colonies and eliminate the need for fresh vertebrate blood.


  • Open Access

    Fresh-blood-free diet for rearing malaria mosquito vectors

    by Joana Marques, João C. R. Cardoso, Rute C. Felix, Rosa A. G. Santana, Maria das Graças Barbosa Guerra, Deborah Power, Henrique Silveira

    Mosquito breeding depends on the supply of fresh vertebrate blood, a major bottleneck for large-scale production of Anopheles spp. Feeding alternatives to fresh blood are thus a priority for research, outdoor large-cage trials and control interventions. Several artificial meal compositions were tested and Anopheles oogenesis, egg laying and development into the next generation of adult mosquitoes were followed. We identified blood-substitute-diets that supported ovarian development, egg maturation and fertility as well as, low progeny larval mortality, and normal development of offspring into adult mosquitoes. The formulated diet is an effective artificial meal, free of fresh blood that mimics a vertebrate blood meal and represents an important advance for the sustainability of Anopheles mosquito rearing in captivity.


  • Open Access

    Polyamidoamine Nanoparticles for the Oral Administration of Antimalarial Drugs

    by Elisabet Martí Coma-Cros, Arnau Biosca, Joana Marques, Laura Carol, Patricia Urbán, Diana Berenguer, Maria Cristina Riera, Michael Delves, Robert E. Sinden, Juan José Valle-Delgado, et al.

    Current strategies for the mass administration of antimalarial drugs demand oral formulations to target the asexual Plasmodium stages in the peripheral bloodstream, whereas recommendations for future interventions stress the importance of also targeting the transmission stages of the parasite as it passes between humans and mosquitoes. Orally administered polyamidoamine (PAA) nanoparticles conjugated to chloroquine reached the blood circulation and cured Plasmodium yoelii-infected mice, slightly improving the activity of the free drug and inducing in the animals immunity against malaria. Liquid chromatography with tandem mass spectrometry analysis of affinity chromatography-purified PAA ligands suggested a high adhesiveness of PAAs to Plasmodium falciparum proteins, which might be the mechanism responsible for the preferential binding of PAAs to Plasmodium-infected erythrocytes vs. non-infected red blood cells. The weak antimalarial activity of some PAAs was found to operate through inhibition of parasite invasion, whereas the observed polymer intake by macrophages indicated a potential of PAAs for the treatment of certain coinfections such as Plasmodium and Leishmania. When fluorescein-labeled PAAs were fed to females of the malaria mosquito vectors Anopheles atroparvus and Anopheles gambiae, persistent fluorescence was observed in the midgut and in other insect’s tissues. These results present PAAs as a versatile platform for the encapsulation of orally administered antimalarial drugs and for direct administration of antimalarials to mosquitoes, targeting mosquito stages of Plasmodium.


  • Open Access

    Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery

    by Joana Marques, Juan José Valle-Delgado, Patricia Urbán, Elisabet Baró, Rafel Prohens, Alfredo Mayor, Pau Cisteró, Michael Delves, Robert E. Sinden, Christian Grandfils, et al.


  • Heparin micropatterning onto fouling-release perfluoropolyether-based polymers via photobiotin activation

    by Caterina Credi, Carmela De Marco, Elena Molena, Mateu Pla Roca, Josep Samitier Martí, Joana Marques, Xavier Fernàndez-Busquets, Marinella Levi, Stefano Turri


  • Open Access

    Marine organism sulfated polysaccharides exhibiting significant antimalarial activity and inhibition of red blood cell invasion by Plasmodium

    by Joana Marques, Eduardo Vilanova, Paulo A. S. Mourão, Xavier Fernàndez-Busquets

    The antimalarial activity of heparin, against which there are no resistances known, has not been therapeutically exploited due to its potent anticoagulating activity. Here, we have explored the antiplasmodial capacity of heparin-like sulfated polysaccharides from the sea cucumbersLudwigothurea griseaandIsostichopus badionotus, from the red algaBotryocladia occidentalisand from the marine spongeDesmapsamma anchorata.In vitroexperiments demonstrated for most compounds significant inhibition ofPlasmodium falciparumgrowth at low-anticoagulant concentrations. This activity was found to operate through inhibition of erythrocyte invasion byPlasmodium, likely mediated by a coating of the parasite similar to that observed for heparin.In vivofour-day suppressive tests showed that several of the sulfated polysaccharides improved the survival ofPlasmodium yoelii-infected mice. In one animal treated withI. badionotusfucan parasitemia was reduced from 10.4% to undetectable levels and Western blot analysis revealed the presence of antibodies againstP. yoeliiantigens in its plasma. The retarded invasion mediated by sulfated polysaccharides and the ensuing prolonged exposure ofPlasmodiumto the immune system, can be explored for the design of new therapeutic approaches against malaria where heparin-related polysaccharides of low anticoagulating activity could play a dual role as drugs and as potentiators of immune responses.


  • Application of heparin as a dual agent with antimalarial and liposome targeting activities toward Plasmodium-infected red blood cells

    by Joana Marques, Ernest Moles, Patricia Urbán, Rafel Prohens, Maria Antònia Busquets, Chantal Sevrin, Christian Grandfils, Xavier Fernàndez-Busquets


  • Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium

    by Patricia Urbán, Juan José Valle-Delgado, Nicolò Mauro, Joana Marques, Amedea Manfredi, Matthias Rottmann, Elisabetta Ranucci, Paolo Ferruti, Xavier Fernàndez-Busquets


  • Nanotools for the Delivery of Antimicrobial Peptides

    by Patricia Urban, Juan Jose Valle-Delgado, Ernest Moles, Joana Marques, Cinta Diez, Xavier Fernandez-Busquets

    Antimicrobial peptide drugs are increasingly attractive therapeutic agents as their roles in physiopathological processes are being unraveled and because the development of recombinant DNA technology has made them economically affordable in large amounts and high purity. However, due to lack of specificity regarding the target cells, difficulty in attaining them, or reduced half-lives, most current administration methods require high doses. On the other hand, reduced specificity of toxic drugs demands low concentrations to minimize undesirable side-effects, thus incurring the risk of having sublethal amounts which favour the appearance of resistant microbial strains. In this scenario, targeted delivery can fulfill the objective of achieving the intake of total quantities sufficiently low to be innocuous for the patient but that locally are high enough to be lethal for the infectious agent. One of the major advances in recent years has been the size reduction of drug carriers that have dimensions in the nanometer scale and thus are much smaller than —and capable of being internalized by— many types of cells. Among the different types of potential antimicrobial peptide-encapsulating structures reviewed here are liposomes, dendritic polymers, solid core nanoparticles, carbon nanotubes, and DNA cages. These nanoparticulate systems can be functionalized with a plethora of biomolecules providing specificity of binding to particular cell types or locations; as examples of these targeting elements we will present antibodies, DNA aptamers, cellpenetrating peptides, and carbohydrates. Multifunctional Trojan horse-like nanovessels can be engineered by choosing the adequate peptide content, encapsulating structure, and targeting moiety for each particular application.